Edition:
United Kingdom

Obseva SA (OBSV.OQ)

OBSV.OQ on NASDAQ Stock Exchange Global Select Market

16.89USD
18 Sep 2018
Change (% chg)

$0.40 (+2.43%)
Prev Close
$16.49
Open
$16.64
Day's High
$17.08
Day's Low
$16.30
Volume
53,725
Avg. Vol
28,085
52-wk High
$20.31
52-wk Low
$7.01

Chart for

About

Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH)... (more)

Overall

Beta: --
Market Cap(Mil.): $257.50
Shares Outstanding(Mil.): 29.63
Dividend: --
Yield (%): --

Financials

  OBSV.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.86 -- --
ROI: -66.09 1.78 14.61
ROE: -68.51 3.27 16.33

ObsEva plans Swiss listing; trading debut on July 13

ZURICH ObsEva , a Switzerland-based drug development company, said on Friday it plans a secondary listing on the SIX Swiss Exchange in Zurich and trading debut on July 13, as the firm seeks to gain more visibility among European investors.

06 Jul 2018

UPDATE 1-ObsEva plans Swiss listing; trading debut on July 13

ZURICH, July 6 ObsEva, a Switzerland-based drug development company, said on Friday it plans a secondary listing on the SIX Swiss Exchange in Zurich and trading debut on July 13, as the firm seeks to gain more visibility among European investors.

06 Jul 2018

ObsEva plans Swiss listing; trading debut on July 13

ZURICH, July 6 ObsEva, a Switzerland-based drug development company, said on Friday it is keen on a secondary listing on the SIX Swiss Exchange in Zurich, with a trading debut on July 13, as the firm seeks to gain more notice from European investors.

06 Jul 2018

Earnings vs. Estimates